المؤلفون: Schneider, B. P., Li, L., Shen, F., Miller, K. D., Radovich, M., O'Neill, A., Gray, R. J., Lane, D., Flockhart, D. A., Jiang, G., Wang, Z., Lai, D., Koller, D., Pratt, J. H., Dang, C. T., Northfelt, D., Perez, E. A., Shenkier, T., Cobleigh, M., Smith, M. L., Railey, E., Partridge, A., Gralow, J., Sparano, J., Davidson, N. E., Foroud, T., Sledge, G. W.

المساهمون: Department of Medicine, IU School of Medicine

المصدر: Publisher

مصطلحات موضوعية: Angiogenesis Inhibitors, adverse effects, Antibodies, Monoclonal, Humanized, Breast Neoplasms, drug therapy, Hypertension, chemically induced, Membrane Glycoproteins, genetics, Nerve Tissue Proteins

وصف الملف: application/pdf

العلاقة: British Journal of Cancer; Schneider, B. P., Li, L., Shen, F., Miller, K. D., Radovich, M., O’Neill, A., … Sledge, G. W. (2014). Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100. British Journal of Cancer, 111(6), 1241–1248. http://doi.org/10.1038/bjc.2014.430Test; https://hdl.handle.net/1805/8853Test

الإتاحة: https://doi.org/10.1038/bjc.2014.430Test
https://hdl.handle.net/1805/8853Test

المؤلفون: Schneider, B P, Li, L, Shen, F, Miller, K D, Radovich, M, O'Neill, A, Gray, R J, Lane, D, Flockhart, D A, Jiang, G, Wang, Z, Lai, D, Koller, D, Pratt, J H, Dang, C T, Northfelt, D, Perez, E A, Shenkier, T, Cobleigh, M, Smith, M L, Railey, E, Partridge, A, Gralow, J, Sparano, J, Davidson, N E, Foroud, T, Sledge, G W

المصدر: British Journal of Cancer ; volume 111, issue 6, page 1241-1248 ; ISSN 0007-0920 1532-1827

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1038/bjc.2014.430Test
http://www.nature.com/articles/bjc2014430.pdfTest
http://www.nature.com/articles/bjc2014430Test